Aesthetic medicine in the GCC region has moved from a “boutique” concept to becoming a mainstream element in healthcare, and this has happened in the last ten years. The rising interest in non-invasive procedures, energy-based technologies, and skin rejuvenation systems has completely changed the way aesthetic medicine is practiced in the UAE and the region. Industry reports indicate a steady growth rate in the aesthetic device market in the Middle East, attributed to the growth in private healthcare and medical tourism in the region. Market coverage from regional publications highlights an expanding presence of distributors who also provide training and technical services, reflecting a shift toward integrated operational support in the sector (Al Bayan, 2023; Gulf News, 2023).
Since its inception in 2016, DUBIMED MEDICAL SUPPLIES TRADING LLC has been based in Dubai. It supplies aesthetic and medical devices, and it also works as a service-based intermediary for those who operate healthcare supply chains. Being based in Dubai, it is at a logistical and regulatory juncture for the region. Since its inception, Safi Rajab has directed DUBIMED toward supporting clinics across the UAE and, subsequently, across the GCC, positioning the company as a regional operational partner rather than solely a distributor.
Rather than functioning solely as a product reseller, DUBIMED integrates device supply with clinical and operational support. Its activities include importing and distributing aesthetic and dermatology systems manufactured by international companies. These systems often involve energy-based or ultrasound-driven technologies used for skin tightening and dermatological treatments. The company coordinates logistics for installation and delivery, which is a critical factor in a region where regulatory clearance, customs processes, and cross-border shipment require structured oversight. The company also manages supply chain processes for multiple aesthetic technology partners beyond Sofwave, reflecting a broader operational footprint (DUBIMED Media Center, 2023).
Clinical training forms another element of its model. DUBIMED provides sessions designed to support healthcare professionals in the use of newly installed systems. In markets where procedural safety and practitioner certification are closely monitored, such training contributes to compliance and standardized practice. Published content from the company’s Media Center highlights training on device handling, patient safety protocols, and procedural demonstrations, indicating a structured educational role (DUBIMED Media Center, 2023). The company also offers biomedical technical support, covering maintenance and servicing of installed equipment. This technical layer reflects a broader shift in the aesthetic medicine sector, where device uptime and after-sales service influence clinic operations.
Marketing coordination services are also integrated into the company’s offering. According to published descriptions on its Media Center, DUBIMED supports aesthetic clinics with campaign planning related to the devices it distributes. This function links technology supply with patient outreach, reflecting the commercial nature of private aesthetic medicine in the Gulf. While such services are common in competitive healthcare markets, their inclusion within a distribution model indicates an effort to position the company as an operational partner rather than a transactional supplier.
In December 2022, DUBIMED entered into a distribution agreement with Sofwave Medical Ltd. The agreement authorized DUBIMED to distribute Sofwave’s ultrasound-based aesthetic systems in the UAE. Ultrasound-driven devices have gained wider adoption as patient demand shifts toward non-surgical treatments. Regional reporting noted that the Sofwave collaboration was part of a larger trend of Gulf distributors forming partnerships with international technology providers to meet local clinic demand (Al Bayan, 2023). The partnership illustrates the company’s engagement with international manufacturers seeking regional representation. It also reflects cross-border commercial ties that have expanded within the healthcare technology sector.
DUBIMED participated in the 8th Middle East International Dermatology & Aesthetic Medicine Conference & Exhibition, held in September 2023 at the Dubai World Trade Centre. The MEIDAM conference is a meeting place for dermatologists, aesthetic doctors, and device makers in the region. At this conference, DUBIMED presented its ultrasound-based skin treatment solutions from its portfolio. The participation of the company and the display of their non-invasive technology solutions were reported by business media in the region. Additional coverage by Gulf News highlighted the company’s broader portfolio at MEIDAM 2023, including multiple aesthetic technologies and demonstration sessions for clinic professionals (Gulf News, 2023).
Beyond events and partnerships, DUBIMED maintains a Media Center on its official website. The published material focuses on aesthetic medical supplies, logistics, marketing support, clinical training, and biomedical services in the UAE. While much of this content originates from the company itself, additional mentions have appeared in regional business publications such as CEO Weekly, UAE Stories, Gulf Today, The Arabian Post, and Economic Insider. The extent of independent investigative coverage remains limited, yet the presence of business media references indicates engagement with regional corporate platforms. The Media Center content also outlines the company’s operational integration of logistics, marketing, and technical services, which supplements distribution activities (DUBIMED Media Center, 2023).
Since 2016, the company has expanded its geographic footprint across the Gulf Cooperation Council states. Healthcare investment across these markets has remained substantial, and private clinics and specialty centers have continued to grow in number. As aesthetic services become more common, distributors and service providers operate as connectors between global device innovators and local practitioners. DUBIMED’s operational model aligns with this intermediary function. The company emphasizes structured operational support, including cross-border logistics and clinic onboarding, as a core part of its service offering (DUBIMED Media Center, 2023).
The company has reported receiving participation certificates and recognition acknowledgments from manufacturing partners for collaboration and educational support initiatives. Its development since 2016 follows a familiar commercial pattern in the medical supply industry, shaped by domestic demand and partner manufacturers, without large-scale acquisitions along the way.
In short, DUBIMED MEDICAL SUPPLIES TRADING LLC can be considered as an example of a healthcare supply chain middleman company in aesthetic medicine based in the Gulf. Established in 2016 by Safi Rajab, the company brings together distribution, training, servicing, logistics management and marketing support under one umbrella. Its deals, including the 2022 collaboration with Sofwave Medical Ltd., and the 2023 MEIDAM event, indicate a pursuit of the developing regional market. Even as aesthetic medicine takes off in the Gulf, companies with a similar business model to this continue to be part of the commercial infrastructure around clinical practice.
